Balchem Corp. achieved a milestone with $1 billion in annual sales, marking its highest revenue to date, while securing a new $18 million investment from a major institutional investor. The developments underscore robust business performance and growing market confidence in the industrial chemicals sector.
- Balchem recorded $1 billion in annual sales, its highest ever.
- A new institutional investor committed $18 million to Balchem.
- Adjusted EBITDA increased 15% year-over-year.
- Gross margins expanded by 120 basis points.
- Debt-to-EBITDA ratio remained below 2.0x.
- BALC shares rose over 6% in after-hours trading.
Balchem Corp. (BALC) has posted a record $1 billion in annual sales, reflecting strong demand across its specialty chemical segments, including nutritional additives and functional ingredients for food, pharmaceuticals, and animal health markets. The achievement follows a year of strategic expansion, operational efficiency gains, and increased global penetration, particularly in emerging economies. The company's success attracted a significant new investor, committing $18 million in equity to its capital base. This institutional infusion signals confidence in Balchem’s long-term growth trajectory and margin resilience amid evolving supply chain dynamics and inflationary pressures. The investment was made by a U.S.-based asset management firm with a focus on industrials and specialty chemicals, though the firm’s name remains undisclosed. Financial metrics highlight Balchem’s improving profitability: adjusted EBITDA rose 15% year-over-year, and gross margins expanded by 120 basis points. These gains were supported by higher pricing power and cost optimization initiatives, including automation upgrades at its North American manufacturing facilities. The company also maintained a debt-to-EBITDA ratio below 2.0x, indicating sound financial leverage. The stock reaction was immediate, with BALC shares rising over 6% in after-hours trading. Investors are particularly responsive to the combination of top-line growth, margin improvement, and fresh capital, which may support future M&A opportunities or R&D investments. The broader industrial chemicals sector, tracked via indices including CL=F (crude oil) and ^VIX (market volatility), saw modest gains, suggesting that Balchem’s performance is contributing to positive sentiment in the materials space.